Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CHEK2 |
| Variant | T367fs |
| Impact List | frameshift |
| Protein Effect | loss of function |
| Gene Variant Descriptions | CHEK2 T367fs results in a change in the amino acid sequence of the Chek2 protein beginning at aa 367 of 543, resulting in premature truncation of the functional protein within the kinase domain (UniProt.org). T367fs results in decreased protein stability and reduced Chk2 phosphorylation in response to DNA damage (PMID: 16982735), and loss of Kap1 phosphorylation at serine (S)-473 in in vitro assays and in cell culture (PMID: 31050813, PMID: 34903604), and loss of kinase activity in an in vitro assay (PMID: 11053450). |
| Associated Drug Resistance | |
| Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 T367fs |
| Transcript | NM_007194.4 |
| gDNA | chr22:g.(28695870_28695871) |
| cDNA | c.(1099_1098) |
| Protein | p.T367fs |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_007194.3 | chr22:g.(28695870_28695871) | c.(1099_1098) | p.T367fs | RefSeq | GRCh38/hg38 |
| NM_007194.4 | chr22:g.(28695870_28695871) | c.(1099_1098) | p.T367fs | RefSeq | GRCh38/hg38 |
| NM_007194 | chr22:g.(28695870_28695871) | c.(1099_1098) | p.T367fs | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|